director
ORLANDO (May 30, 2009)?When a cancer patient and his or her doctor discuss the value of a treatment option, the conversation usually centers on a consideration of the treatment's medical benefits versus its possible side effects for the patient.
Driven by rising health care costs at home, nearly 1 million Californians cross the border each year to seek medical care in Mexico, according a new paper by UCLA researchers and colleagues published today in the journal Medical Care.
A Monash-led research team has discovered an entirely new mechanism that promotes blood clot formation ? a major breakthrough that will impact on treatment and prevention of heart disease and stroke.
The discovery is today published in the prestigious Nature Medicine journal.
Berkeley -- Trying to quit cigarettes but don't know how? A new analysis led by researchers at the University of California, Berkeley, School of Public Health, suggests that Web- and computer-based smoking cessation programs are worth a try, and fortunately during these tough economic times, many of them are free.
GAINESVILLE, Fla. ? Brain may win out over brawn as the primary cause of breathing problems in children with a severe form of muscular dystrophy known as Pompe disease.
SAN DIEGO ? (May 25, 2009) Researchers from the La Jolla Institute for Allergy & Immunology have pinpointed the cellular defect that increases the likelihood, among eczema sufferers, of developing eczema vaccinatum, a severe and potentially fatal reaction to the smallpox vaccine.
DURHAM, N.C. ?An emerging form of the pathogenic yeast Candida is able to complete a full sexual cycle in a test tube, even though it's missing the genes for reproduction. And it may also do so while infecting us, according to Duke University Medical Center researchers.
It appears that some superbugs have evolved to develop the ability to manipulate the immune system to everyone's advantage.
Someone who has a low level of response (LR) to alcohol, meaning relatively little reaction to alcohol, has a higher risk for developing alcohol-use disorders (AUDs).
NEW YORK ? Results of a phase I clinical trial of a novel herb-based therapeutic called Zyflamend have demonstrated that the therapy is associated with minimal toxicity and no serious adverse events in men at high-risk for developing prostate cancer.
ARLINGTON, VA - Dr. William Phillips, an Office of Naval Research (ONR) funded Nobel Prize-winning physicist, delivered the final lecture at ONR's spring distinguished lecture series May 19. Phillips' compelling presentation, titled "Time, Einstein and the Coolest Stuff," highlighted the importance of basic research and ONR's legacy of support for innovative scientists.
(PHILADELPHIA) ? Women with ductal carcinoma in situ (DCIS) who exhibit an overexpression of the protein HER2/neu have a six-fold increase in risk of invasive breast cancer, according to a new study from the University of Pennsylvania School of Medicine.
If you own a computer, chances are you have experienced the aftermath of a nasty virus at some point. In contrast, there have been no major outbreaks of mobile phone viral infection, despite the fact that over 80 percent of Americans now use these devices.
Cambridge, MA ? May, 21, 2009 ? Agios Pharmaceuticals, the first biopharmaceutical company focused on discovering and developing novel cancer metabolism drugs, announced that the leading scientific journal Science has published a review article, "Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation," authored by two of its founders, Lewis C.
For the first time, a combination of aspirin and the anti-platelet drug dipyridamole has been shown to significantly reduce blockages and extend the useful life of new artery-vein access grafts used for hemodialysis, according to a study by the Dialysis Access Consortium (DAC).
